Surmodics to Webcast Second Quarter Fiscal 2021 Earnings Conference Call on April 28

Rhea-AI Summary

Surmodics, Inc. (Nasdaq: SRDX) will host a live webcast of its Q2 fiscal 2021 conference call on April 28 at 7:30 a.m. CT. The earnings release will be made prior to market opening. CEO Gary Maharaj and CFO Tim Arens will discuss the financial results during the call. An audio replay will be available from 10:30 a.m. CT on the same day until May 5. Surmodics focuses on surface modification technologies for medical devices and provides chemical components for diagnostic tests, aiming to improve disease detection and treatment.

Positive

• Company is the global leader in surface modification technologies for intravascular medical devices.
• Focus on addressing unmet clinical needs through differentiated medical devices.
• Enhanced device design, development, and manufacturing capabilities.

Negative

• None.

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its second quarter fiscal 2021 conference call on Wednesday, April 28, at 7:30 a.m. CT (8:30 a.m. ET). The Company will issue an earnings news release before the market opens that morning.

Gary Maharaj, president and chief executive officer, and Tim Arens, senior vice president of finance and chief financial officer, will recap the second quarter fiscal 2021 financial results and accomplishments. To access the webcast, go to the investor relations portion of the Company’s website at https://surmodics.gcs-web.com the day of the conference call and click on the webcast icon.

An audio replay will be available beginning at 10:30 a.m. CT on Wednesday, April 28, until 10:30 a.m. CT on Wednesday, May 5, and can be accessed by dialing 888-203-1112 and entering conference call ID passcode 8882132. In addition, the conference call audio and transcript will be archived on the Company’s website following the call.

About Surmodics, Inc.

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Surmodics is pursuing highly differentiated medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company’s expertise in proprietary surface technologies, along with enhanced device design, development, and manufacturing capabilities. The Company mission remains to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the SEC.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210420005151/en/

FAQ

When is Surmodics' Q2 fiscal 2021 conference call?

Surmodics' Q2 fiscal 2021 conference call is scheduled for April 28 at 7:30 a.m. CT.

How can I access the Surmodics conference call webcast?

You can access the conference call webcast through the investor relations section of Surmodics' website.

What will be discussed during Surmodics' Q2 earnings call?

CEO Gary Maharaj and CFO Tim Arens will recap the financial results and accomplishments for Q2 fiscal 2021.

Is there a replay available for the Surmodics earnings call?

Yes, an audio replay will be available from 10:30 a.m. CT on April 28 until May 5.

What is Surmodics' focus in the medical device industry?

Surmodics focuses on surface modification technologies for medical devices and provides components for in vitro diagnostic tests.